Search Page

1

Cite

Share

Intra- and interassay variations of two thrombin generation methods.

Mori F, Genuardo C, Nannizzi S, Farina C. Mori F, et al. Among authors: nannizzi s. Int J Lab Hematol. 2021 Aug;43(4):O218-O220. doi: 10.1111/ijlh.13524. Epub 2021 Mar 24. Int J Lab Hematol. 2021. PMID: 33759358 No abstract available.

Cite

Share

2

Cite

Share

Post-translational modifications and antioxidant properties of different therapeutic human serum albumins.

Mori F, Natali L, Danesi R, Nannizzi S, Farina C. Mori F, et al. Among authors: nannizzi s. Int J Biol Macromol. 2021 Jul 31;183:927-935. doi: 10.1016/j.ijbiomac.2021.05.046. Epub 2021 May 7. Int J Biol Macromol. 2021. PMID: 33971232

Cite

Share

3

Cite

Share

In vitro studies on gemcitabine combinations with other antiblastics.

Giovannetti E, Danesi R, Mey V, Nannizzi S, Pasqualetti G, Del Tacca M. Giovannetti E, et al. Among authors: nannizzi s. Ann Oncol. 2006 May;17 Suppl 5:v17-19. doi: 10.1093/annonc/mdj943. Ann Oncol. 2006. PMID: 16807450 Free article. Review.

Cite

Share

4

Cite

Share

Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer.

Giovannetti E, Mey V, Nannizzi S, Pasqualetti G, Del Tacca M, Danesi R. Giovannetti E, et al. Among authors: nannizzi s. Mol Cancer Ther. 2006 Jun;5(6):1387-95. doi: 10.1158/1535-7163.MCT-06-0004. Mol Cancer Ther. 2006. PMID: 16818496 Review.

Cite

Share

5

Cite

Share

Correlation between cytidine deaminase genotype and gemcitabine deamination in blood samples.

Giovannetti E, Laan AC, Vasile E, Tibaldi C, Nannizzi S, Ricciardi S, Falcone A, Danesi R, Peters GJ. Giovannetti E, et al. Among authors: nannizzi s. Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):720-5. doi: 10.1080/15257770802145447. Nucleosides Nucleotides Nucleic Acids. 2008. PMID: 18600531

Cite

Share

6

Cite

Share

Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines.

Crea F, Giovannetti E, Cortesi F, Mey V, Nannizzi S, Gallegos Ruiz MI, Ricciardi S, Del Tacca M, Peters GJ, Danesi R. Crea F, et al. Among authors: nannizzi s. Mol Cancer Ther. 2009 Jul;8(7):1964-73. doi: 10.1158/1535-7163.MCT-09-0027. Epub 2009 Jun 16. Mol Cancer Ther. 2009. PMID: 19531575

Cite

Share

7

Cite

Share

Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma.

Funel N, Giovannetti E, Del Chiaro M, Mey V, Pollina LE, Nannizzi S, Boggi U, Ricciardi S, Del Tacca M, Bevilacqua G, Mosca F, Danesi R, Campani D. Funel N, et al. Among authors: nannizzi s. Lab Invest. 2008 Jul;88(7):773-84. doi: 10.1038/labinvest.2008.40. Epub 2008 May 19. Lab Invest. 2008. PMID: 18490900

Cite

Share

8

Cite

Share

Single nucleotide polymorphisms and clinical outcome in patients with biliary tract carcinoma treated with epirubicin, cisplatin and capecitabine.

Pacetti P, Giovannetti E, Mambrini A, Nannizzi S, Orlandi M, Tartarini R, Del Freo A, Del Tacca M, Danesi R, Cantore M. Pacetti P, et al. Among authors: nannizzi s. Anticancer Res. 2009 May;29(5):1835-40. Anticancer Res. 2009. PMID: 19443413 Free article.

Cite

Share

9

Cite

Share

Synergistic cytotoxicity and molecular interaction on drug targets of sorafenib and gemcitabine in human pancreas cancer cells.

Ricciardi S, Mey V, Nannizzi S, Pasqualetti G, Crea F, Del Tacca M, Danesi R. Ricciardi S, et al. Among authors: nannizzi s. Chemotherapy. 2010;56(4):303-12. doi: 10.1159/000320031. Epub 2010 Aug 13. Chemotherapy. 2010. PMID: 20714148

Cite

Share

10

Cite

Share

In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients.

Mey V, Giovannetti E, De Braud F, Nannizzi S, Curigliano G, Verweij F, De Cobelli O, Pece S, Del Tacca M, Danesi R. Mey V, et al. Among authors: nannizzi s. Br J Cancer. 2006 Aug 7;95(3):289-97. doi: 10.1038/sj.bjc.6603242. Epub 2006 Jul 25. Br J Cancer. 2006. PMID: 16868547 Free PMC article. Clinical Trial.

Cite

Share